Liconic US Inc

CuriRx Inc. is a Wilmington, MA-based contract research organization specializing in innovative drug development solutions. They offer a wide array of services including formulation development, advanced bioprocessing, and analytical support for both biologics and small molecule pharmaceuticals. The company's CuriLytics platform assists developers of complex biotherapeutics at any stage of the process. CuriRx emphasizes collaboration with pharmaceutical companies of all sizes, striving to alleviate product development bottlenecks and enhance therapeutic care standards. Generated from the website

ChemGenes Corporation, a biotechnology company, recently relocated to a state of the art facility in Wilmington, Massachusetts. We have consistently been a strong partner to researchers engaged in the field of DNA/RNA synthesis for 23 years. By starting out as a supplier of 'Ultra Pure Products' and then also by becoming an active Contract Researcher, ChemGenes Corporation has achieved unparalleled expertise in the field of DNA/RNA synthesis. Thus, all of us at ChemGenes have the opportunity and great pleasure to serve a vast number of scientists in the US and all over the world.ChemGenes' product lines include phosphoramidites for RNA and DNA synthesis, Antisense phosphoramidites, modified bases for DNA, as well as RNA modification. In addition, we produce a variety of modified phosphoramidites for the introduction of chromophores and ligands. The availability of prepacked disposable columns of various pore sizes, loadings, low volume columns, ancillary reagents in configurations suitable for each synthesizer, and DNA purification cartridges is another way ChemGenes meets its customers needs.A large variety of Reagents for the synthesis of DNA/RNA are also available, which include many natural and modified nucleoside bases, tetrazole, 5-thioethyltetrazole, DMT-chloride, DMT protected deoxy and ribo nucleosides, 2'-O-methyl and 2'-O-propargyl nucleosides, silyl protected ribonucleosides, several types of phosphorylating reagents, and many more.

Azurity Pharmaceuticals, Inc., based in Wilmington, MA, is a privately held company dedicated to providing innovative, high-quality medicines for overlooked patient populations. With a global presence in over 50 countries, the company boasts a diverse portfolio of 30 marketed brands across 10 dosage forms and 9 key therapeutic areas. Leveraging a NextGen Commercial Model powered by data analytics and AI-driven digital tools, Azurity enhances market reach and stakeholder engagement. Their commitment to patient care is evident through their expanding product offerings, which have benefited millions worldwide. Generated from the website